Literature DB >> 2222633

Risk factors for preterm premature rupture of the fetal membranes.

C B Hadley1, D M Main, S G Gabbe.   

Abstract

Preterm premature rupture of the membranes (PPROM) is a significant cause of prematurity, accounting for approximately one third of preterm births in the United States. PPROM occurs in approximately 0.7-2% of all pregnancies nationally, and has a reported recurrence rate of 21%. The elucidation of potential risk factors for PPROM could contribute to a better understanding of its etiology. To study the contributions of 20 potential risk factors, we undertook a case-control study in our clinic population, which has a 5-6% incidence of PPROM. One hundred and thirty-three patients experiencing PPROM were matched for race, age, parity and gestational age with undelivered patients. Studies performed included ultrasonographic examinations, blood levels of ascorbic acid and zinc, microbiologic assays, patient questionnaires, and chart reviews. After stratification of both groups into subgroups based on matching criteria, summary tests of significance and Mantel-Haenszel tests of odds ratios were performed. On univariate analysis the following factors achieved significance at the p less than 0.05 level with 95% confidence intervals: 1) previous history of PPROM 2) smoking (dose related) 3) fundal location of the placenta in the present pregnancy. 4) a prior history of cerclage. After regression analysis, we concluded that smoking and history of previous PPROM were found to be risk factors for PPROM in our inner city black population.

Entities:  

Mesh:

Year:  1990        PMID: 2222633     DOI: 10.1055/s-2007-999527

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  13 in total

1.  Childhood outcomes following preterm prelabor rupture of the membranes (PPROM): a population-based record linkage cohort study.

Authors:  C L Roberts; P Wagland; S Torvaldsen; J R Bowen; J P Bentley; J M Morris
Journal:  J Perinatol       Date:  2017-08-03       Impact factor: 2.521

2.  Placental location and pregnancy outcome.

Authors:  Shumaila Zia
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-12-01

3.  The impact of tobacco use on preterm premature rupture of the membranes.

Authors:  Robert L Andres; Yuan Zhao; Mark A Klebanoff; John C Hauth; Steve N Caritis; J Christopher Carey; Ronald J Wapner; Jay D Iams; Kenneth J Leveno; Menachem Miodovnik; Baha Sibai; J Peter Van Dorsten; Mitchell P Dombrowski; Mary J O'Sullivan; Oded Langer
Journal:  Am J Perinatol       Date:  2012-08-28       Impact factor: 1.862

Review 4.  Genetic and epigenetic influences associated with intrauterine growth restriction due to in utero tobacco exposure.

Authors:  Melissa Suter; Adi Abramovici; Kjersti Aagaard-Tillery
Journal:  Pediatr Endocrinol Rev       Date:  2010-12

Review 5.  Risks and benefits of nicotine to aid smoking cessation in pregnancy.

Authors:  D A Dempsey; N L Benowitz
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States.

Authors:  Hamisu M Salihu; Muktar H Aliyu; Bosny J Pierre-Louis; Greg R Alexander
Journal:  Matern Child Health J       Date:  2003-12

Review 7.  Maternal smoking in pregnancy and its influence on childhood asthma.

Authors:  Angela Zacharasiewicz
Journal:  ERJ Open Res       Date:  2016-07-29

Review 8.  Spontaneous premature birth as a target of genomic research.

Authors:  Mikko Hallman; Antti Haapalainen; Johanna M Huusko; Minna K Karjalainen; Ge Zhang; Louis J Muglia; Mika Rämet
Journal:  Pediatr Res       Date:  2018-09-18       Impact factor: 3.756

9.  The role of vitamin C in prevention of preterm premature rupture of membranes.

Authors:  Nayereh Ghomian; Leili Hafizi; Zahra Takhti
Journal:  Iran Red Crescent Med J       Date:  2013-02-05       Impact factor: 0.611

10.  Pharmacological treatment for pregnant women who smoke cigarettes.

Authors:  Bc Chan; G Koren
Journal:  Tob Induc Dis       Date:  2003-09-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.